
Cheaper Versions Of HIV Prevention Drugs For 120 Low-Income Countries
LAGOS OCTOBER 7TH (NEWSRANGERS)-Manufacturing Company, Gilead Sciences, has announced that cheaper versions of the “gamechanger” HIV prevention drug, lenacapavir, will be made available in 120 low and middle-income countries. Currently, the drug is priced at $42,250 annually in the US under the brand name Sunlenca, but researchers believe it could be produced for as low…